Attovia Therapeutics, Inc. (ATTO)

SEC filing

Attovia Therapeutics, Inc.

ATTO · CIK 2058707

4 · Aug 10, 2026 · venBio Global Strategic Fund IV bought 382.35K shares at $17.00/share ($6.5M); converted 3.80M shares

venBio Global Strategic Fund IV bought 382.35K shares at $17.00/share ($6.5M); converted 3.80M shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.